Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
16 oct. 2024 16h15 HE
|
OncoCyte Corporation
Oncocyte Announces Participation in the LD Micro Main Event XVII
Conference in Los Angeles
Oncocyte Signs Leading Transplant Centers in US and Germany
02 oct. 2024 18h41 HE
|
OncoCyte Corporation
GraftAssure™ research assay adopted by two research hospitals that are top-five-in-country by organ transplant volumeCompany clears first stage gate in clinical product development process and has...
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
20 août 2024 09h00 HE
|
PRISM MarketView
PRISM MarketView Features Oncocyte CFO Andrea S. James on Her Career and Leadership in Molecular Diagnostics Technology
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
12 août 2024 16h10 HE
|
OncoCyte Corporation
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Oncocyte Announces Successful GraftAssure™ Beta Launch and Q2 2024 Results
08 août 2024 16h05 HE
|
OncoCyte Corporation
Oncocyte Announces Successful GraftAssureTM Beta Launch and Q2 2024 Results
The Eclipse Foundation Announces Agenda and Keynote Speakers for Open Community Experience (OCX 2024), Europe’s Premier Event for Open Source Innovation
06 août 2024 07h00 HE
|
Eclipse Foundation Canada
BRUSSELS, Belgium, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The Eclipse Foundation, one of the world’s largest open source foundations, has unveiled the agenda and speakers for the inaugural Open...
Oncocyte Announces August Investor Conferences Participation
05 août 2024 16h05 HE
|
OncoCyte Corporation
Oncocyte Announces August Investor Conferences Participation
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
01 août 2024 16h05 HE
|
OncoCyte Corporation
Oncocyte to Announce Second Quarter 2024 Financial Results on August 8
MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode
11 juil. 2024 08h00 HE
|
Med Tech Gurus
MedTech Gurus Podcast Features Oncocyte CEO Josh Riggs in "Take Advantage of the Moment" Episode
Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move
24 juin 2024 12h41 HE
|
PRISM MarketView
Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Leadership Move